Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Telangiectasia, Hereditary Hemorrhagic

• Assess Safety and Efficacy of VAD044 in HHT Patients
• Sirolimus for Nosebleeds in HHT
• Efficacy of Nintedanib for Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) Patients
• Tacrolimus Trial for Hereditary Hemorrhagic Telangiectasia (HHT)
• Bevacizumab In Hereditary Hemorrhagic Telangiectasia
• Timolol Gel for Epistaxis in Hereditary Hemorrhagic Telangiectasia
• Propranolol for Epistaxis in Hereditary Hemorrhagic Telangiectasia Patients
• Vitamin D and Hereditary Haemorrhagic Telangiectasia
• Efficacy of Nintedanib Per os as a Treatment for Epistaxis in HHT Disease.
• Pomalidomide for the Treatment of Bleeding in HHT
• Pazopanib Effects on Bleeding in Hereditary Hemorrhagic Telangiectasia
• Pazopanib for the Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia
• Doxycycline for Hereditary Hemorrhagic Telangiectasia
• BABH Study: Efficacy and Safety of Bevacizumab on Severe Bleedings Associated With Hemorrhagic Hereditary Telangiectasia (HHT).
• Treatment of Nasal Staphylococcus Aureus Colonization in Patients With HHT
• Octreotide in Patients With GI Bleeding Due to Rendu-Osler-Weber
• Prospective Pilot Study of Floseal for the Treatment of Anterior Epistaxis in Patients With (HHT)
• Efficacy of a Timolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) - (TEMPO)
• Intranasal Bevacizumab for HHT-Related Epistaxis
• Pomalidomide in Hereditary Hemorrhagic Telangiectasia and Transfusion-Dependent Vascular Ectasia: a Phase I Study
• Evaluation of Pazopanib on Bleeding in Subjects With Hereditary Haemorrhagic Telangiectasia
• Treatment of Hereditary Hemorrhagic Telangiectasia of the Nasal Mucosa by Intranasal Bevacizumab : Search for Effective Dose
• Efficacy of a Bevacizumab Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
• Iron Deficiency and Hereditary Haemorrhagic Telangiectasia
• Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of Concept
• The ELLIPSE Study: A Phase-1 Study Evaluating the Tolerance of Bevacizumab Nasal Spray to Treat Epistaxis in Hereditary Hemorrhagic Telangiectasia
• Efficacy of Thalidomide in the Treatment of Hereditary Hemorrhagic Telangiectasia
• Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia
• North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
• Ranibizumab for the Management of Recurrent Nosebleeds in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
• Submucosal Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
• Topical Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
• Intranasal Submucosal Bevacizumab for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
• Tranexamic Acid and Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
• Phase 2 Study of PEG-Intron in Hereditary Hemorrhagic Telangiectasia
• Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding
• Anti-Estrogen Therapy for Hereditary Hemorrhagic Telangiectasia A Double-Blind Placebo-Controlled Clinical Trial
• ATERO : A Randomised Study With Tranexamic Acid in Epistaxis of Rendu Osler Syndrome
• Phase III Randomized, Placebo-Controlled, Crossover Study of Soy Protein Isolate for Hereditary Hemorrhagic Telangiectasia
• Phase II Pilot Study of Octreotide, a Somatostatin Octapeptide Analog, for Gastrointestinal Hemorrhage in Hormone-Refractory Hereditary Hemorrhagic Telangiectasia and Senile Ectasia